Every 8-K that Alchemy Investments Acquisition Corp 1 Units (ALCYU) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow ALCYU and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ALCYU filings page.
Alchemy Investments Acquisition Corp 1, a special purpose acquisition company, reported that Nasdaq has determined its securities are subject to delisting for failing to comply with Nasdaq IM-5101-2. The rule requires a business combination within 36 months of the IPO registration statement, which became effective on May 4, 2023.
Because Alchemy did not complete an initial business combination by May 4, 2026, Nasdaq will suspend trading of its securities on May 14, 2026 and file Form 25-NSE to remove them from listing. The company will not appeal and expects its securities to begin trading on the over-the-counter market on May 14, 2026.
Alchemy Investments Acquisition Corp 1 filed an 8-K announcing an Investor Presentation prepared with Cartiga, LLC about their potential business combination. The April 2026 presentation, attached as Exhibit 99.1, is being used to brief investors on the proposed transaction.
The filing explains that Alchemy Acquisition Holdings, Inc. intends to submit a Registration Statement on Form S-4 to the SEC, including a preliminary proxy statement/prospectus for the proposed deal. Alchemy plans to mail a definitive proxy statement and proxy card to shareholders for an Extraordinary Meeting once available.
The document includes extensive forward-looking statement and risk disclosures, highlighting uncertainties around closing the business combination, required approvals, Nasdaq listing, redemption levels and Cartiga’s growth. It clarifies that the Investor Presentation is not an offer to sell securities or a solicitation to buy or vote, and that any securities offering would only occur through a compliant prospectus or exemption.
Alchemy Investments Acquisition Corp. 1 filed an 8-K describing a joint press release with Cartiga, LLC about exploring a potential private investment in public equity (PIPE) to support their proposed business combination and post-closing business plan. The parties have begun preliminary talks with potential investors, but have not signed any definitive PIPE agreements and may never do so.
The press release also notes that on March 10, 2026, Cartiga completed the first closing of its new private credit vehicle, the LBS Income Fund, anchored by a subscription from a leading global alternative asset manager. Cartiga is portrayed as a data-driven legal finance platform that has deployed more than $1.9 billion into legal sector investments tied to estimated settlement values exceeding $20 billion.
Alchemy Investments Acquisition Corp 1 reported shareholder actions from its September 4, 2025 annual meeting. Investors approved a charter amendment allowing the company to extend its deadline to complete a business combination on a month-to-month basis, at the directors’ discretion, through September 9, 2026, by depositing into the trust account the lesser of $30,000 or $0.03 per non-redeemed public Class A share per month. Shareholders also ratified CBIZ CPAs P.C. as independent auditor for the fiscal year ending December 31, 2025.
Following the meeting, the company extended its business combination deadline to October 9, 2025 and deposited $22,126.29 into the trust. In connection with the vote, holders of 324,420 Class A shares elected redemption, leading to the removal of approximately $3,791,334.07 (about $11.68 per share) from the trust. After these redemptions, about $8,619,295.70 remains in the trust account, with 4,208,042 Class A shares and one Class B share outstanding.
The filing excerpt describes transaction documents for Alchemy Investments Acquisition Corp 1 and related parties (ALCY, Pubco, Newco and the Company). It specifies the equity being issued as Class A Ordinary Shares with par value $0.0001 and warrants exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share.
The excerpt sets out termination rights and cure mechanics: either party may terminate the Business Combination Agreement for breaches by the other party, subject to 30-day cure periods where a breach is curable. The Company may also terminate if closing has not occurred by the 45th day after the Registration Statement is declared effective and a specified Available Closing Buyer Cash condition has not been met. The document names Mattia Tomba as Chief Executive Officer of Alchemy Investments Acquisition Corp 1.